Strategies for the improvement of thrombolytic agents.
Lijnen
H R
HR
Collen
D
D
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D011994:Recombinant Proteins / Q000235:genetics / Q000502:physiology; D013329:Structure-Activity Relationship; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics / Q000502:physiology
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator